Activation of PKC isoform β₁ at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brainRIGOR, Robert R; HAWKINS, Brian T; MILLER, David S et al.Journal of cerebral blood flow and metabolism. 2010, Vol 30, Num 7, pp 1373-1383, issn 0271-678X, 11 p.Article

A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphomaMORSCHHAUSER, F; SEYMOUR, J. F; CARTRON, G et al.Annals of oncology. 2008, Vol 19, Num 2, pp 247-253, issn 0923-7534, 7 p.Article